Simultaneous determination of gemifloxacin and diuretics in bulk, pharmaceutical dosage forms and human serum by RP-HPLC
AUTOR(ES)
Sultana, Najma, Shamim, Sana, Gul, Mahwish Akhtarand Somia, Arayne, M. Saeed
FONTE
Química Nova
DATA DE PUBLICAÇÃO
2010
RESUMO
An isocratic reversed phase high-performance liquid chromatographic (RP-HPLC) method has been developed for the simultaneous determination of gemifloxacin and diuretics (hydrochlorothiazide and furosemide) in bulk, dosage formulations and human serum at 232 nm. Chromatographic separation was achieved on Purospher Start C18 (250 mm x 4.6 mm, 5 µm) column using mobile phase, methanol: water: acetonitrile (70:25:5 v/v/v) adjusted to pH 3.0 via phosphoric acid 85% having flow rate of 0.8 mL min -1 at room temperature. Calibration curves were linear over range of 0.5-10 µg mL -1 with a correlation coefficient ± 0.999. LOD and LOQ were in the ranges of 0.75-2.56 µg mL -1. Intra and inter-run precision and accuracy results were 98.26 to 100.9.
Documentos Relacionados
- Validated method for the determination of Gemifloxacin in bulk, pharmaceutical formulations and human serum by RP-HPLC: in vitro applications
- Simultaneous RP-HPLC determination of sparfloxacin and dexamethasone in pharmaceutical formulations
- RP-HPLC method development and validation for estimation of rivaroxaban in pharmaceutical dosage forms
- Stability indicating RP-HPLC method development and validation of cefepime and amikacin in pure and pharmaceutical dosage forms
- Stability-indicating RP-HPLC method for simultaneous determination of gatifloxacin and flurbiprofen in binary combination